Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, Hiatt WR, Karas RH, Lovell MB, McDermott MM, et al. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1449–72.

Article  PubMed  Google Scholar 

Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupiter DC. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg. 2016;55:591–9.

Article  PubMed  Google Scholar 

Sampson UK, Fowkes FG, McDermott MM, Criqui MH, Aboyans V, Norman PE, Forouzanfar MH, Naghavi M, Song Y, Harrell FE Jr, et al. Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart. 2014;9:145–58.

Article  PubMed  Google Scholar 

McDermott MM, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, Pearce WH, Hirsch AT, Hanley K, Odom L, et al. Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med. 2002;17:895–904.

Article  PubMed  Google Scholar 

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45:S5–67.

Article  PubMed  Google Scholar 

Willey J, Mentias A, Vaughan-Sarrazin M, McCoy K, Rosenthal G, Girotra S. Epidemiology of lower extremity peripheral artery disease in veterans. J Vasc Surg. 2018;68:527–35.

Article  PubMed  PubMed Central  Google Scholar 

Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384–92.

Article  CAS  PubMed  Google Scholar 

Chen YJ, Lin MS, Hsu KY, Chen CR, Chen CM, Chen W. Prevalence of asymptomatic peripheral arterial disease and related risk factors in younger and elderly patients in Taiwan. Angiology. 2014;65:396–401.

Article  PubMed  Google Scholar 

Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, Wahlberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007;45:1185–91.

Article  PubMed  Google Scholar 

Dua A, Lee CJ. Epidemiology of peripheral arterial disease and critical limb ischemia. Tech Vasc Interv Radiol. 2016;19:91–5.

Article  PubMed  Google Scholar 

Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation. 1993;87:1915–20.

Article  CAS  PubMed  Google Scholar 

Sumpter NA, Saag KG, Reynolds RJ, Merriman TR. Comorbidities in gout and hyperuricemia: causality or epiphenomena? Curr Opin Rheumatol. 2020;32:126–33.

Article  PubMed  Google Scholar 

• Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016. Arthritis Rheumatol. 2019;71:991–9. In this nationally representative survey sample of 5467 participants in the NHANES 2015–2016, they estimated the most recent prevalence rates of gout to be 3.9% among adults in the USA (9.2 million people), with 5.2% [5.9 million] in men and 2.7% [3.3 million] in women.

Article  PubMed  PubMed Central  Google Scholar 

Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116:894–900.

Article  PubMed  Google Scholar 

Johnston KW, Rae M, Steiner G, Kalman PG, Schwartz L, Hill ME, Walker PM. An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease. Ann Vasc Surg. 1988;2:101–7.

Article  CAS  PubMed  Google Scholar 

• Toprover M, Shah B, Oh C, Igel TF, Romero AG, Pike VC, Curovic F, Bang D, Lazaro D, Krasnokutsky S, et al. Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study. Arthritis Res Ther. 2020;22:169. This prospective observational study found initiating guideline-concordant gout treatment reduces intercritical systemic inflammation and improves endothelial-dependent arterial function, particularly in patients without established cardiovascular comorbidities.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krasnokutsky S, Romero AG, Bang D, Pike VC, Shah B, Igel TF, Dektiarev I, Guo Y, Zhong J, Katz SD, et al. Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein. Clin Rheumatol. 2018;37:1903–11.

Article  PubMed  PubMed Central  Google Scholar 

• Calabuig I, Gómez-Garberí M, Andrés M. Gout is prevalent but under-registered among patients with cardiovascular events: a field study. Front Med (Lausanne). 2020;7:560–560. This cross-sectional study found that gout is highly prevalent among patients admitted for cardiovascular events, with suboptimal urate management, despite being a well-established independent CAD risk factor.

Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016. Arthritis & Rheumatology. 2019;71:991–9.

Article  Google Scholar 

Xu D, Zou L, Xing Y, Hou L, Wei Y, Zhang J, Qiao Y, Hu D, Xu Y, Li J, et al. Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis. Can J Cardiol. 2013;29:492–8.

Article  PubMed  Google Scholar 

Shou Z, Zhao Y, Zhang Y, Li S. Risk factors for peripheral arterial disease in elderly patients with type-2 diabetes mellitus: a clinical study. Pak J Med Sci. 2020;36:1344–8.

Article  PubMed  PubMed Central  Google Scholar 

Gao Q, He B, Zhu C, Xiao Y, Wei L, Jia W. Factors associated with lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus: a case-control study. Medicine (Baltimore). 2016;95:e5230.

Article  CAS  PubMed  Google Scholar 

Chen J, Mohler ER, Xie D, Shlipak M, Townsend RR, Appel LJ, Ojo A, Schreiber M, Nessel L, Zhang X, et al. Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease. Nephrol Dial Transplant. 2015;31:1145–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Lu JP, Wu XG, Yang CL. Serum uric acid concentration and asymptomatic hyperuricemia with subclinical organ damage in general population. Angiology. 2014;65:634–40.

Article  CAS  PubMed  Google Scholar 

Zheng L, Yu J, Li J, Li X, Luo Y, Hasimu B, Sun Z, Sun Y, Hu D. Prevalence of and risk factors for peripheral arterial disease among Chinese hypertensive patients with and without known cardiovascular disease. Acta Cardiol. 2008;63:693–9.

Article  PubMed  Google Scholar 

Yang X, Sun K, Zhang W, Wu H, Zhang H, Hui R. Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese. J Vasc Surg. 2007;46:296–302.

Article  PubMed  Google Scholar 

Kuo D, Crowson CS, Gabriel SE, Matteson EL. Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis. Int J Rheumatol. 2014;2014:523897.

Article  PubMed  PubMed Central  Google Scholar 

Tseng CH. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes. Diabet Med. 2004;21:724–9.

Article  CAS  PubMed  Google Scholar 

Sotoda Y, Hirooka S, Orita H, Wakabayashi I. Association of Serum uric acid levels with leg ischemia in patients with peripheral arterial disease after treatment. J Atheroscler Thromb. 2017;24:725–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shankar A, Klein BE, Nieto FJ, Klein R. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis. 2008;196:749–55.

Article  CAS  PubMed  Google Scholar 

Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ. Foot complications in type 2 diabetes: an Australian population-based study. Diabet Med. 2003;20:105–13.

Article  CAS  PubMed  Google Scholar 

Langlois M, De Bacquer D, Duprez D, De Buyzere M, Delanghe J, Blaton V. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis. 2003;168:163–8.

Article  CAS  PubMed  Google Scholar 

Hamur H, Onk OA, Vuruskan E, Duman H, Bakirci EM, Kucuksu Z, Degirmenci H, Buyuklu M, Topal E. Determinants of chronic total occlusion in patients with peripheral arterial occlusive disease. Angiology. 2017;68:151–8.

Article  CAS  PubMed  Google Scholar 

Hjortnaes J, Algra A, Olijhoek J, Huisman M, Jacobs J, van der Graaf Y, Visseren F. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. J Rheumatol. 2007;34:1882–7.

CAS  PubMed  Google Scholar 

Cornejo Del Río V, Mostaza J, Lahoz C, Sánchez-Arroyo V, Sabín C, López S, Patrón P, Fernández-García P, Fernández-Puntero B, Vicent D, et al. Prevalence of peripheral artery disease (PAD) and factors associated: an epidemiological analysis from the population-based screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study. PLoS ONE. 2017;12:e0186220.

Article  PubMed  PubMed Central  Google Scholar 

Celik G, Yilmaz S, Kebapcilar L, Gundogdu A. Central arterial characteristics of gout patients with chronic kidney diseases. Int J Rheum Dis. 2017;20:628–38.

Article  PubMed  Google Scholar 

Chen S-C, Lee M-Y, Huang J-C, Mai H-C, Kuo P-L, Chang J-M, Chen H-C, Yang Y-H. Association of diabetes mellitus with decline in ankle-brachial index among patients on hemodialysis: a 6-year follow-up study. PLoS ONE. 2017;12:e0175363–e0175363.